Rising GLP-1 Costs Prompt Employers to Rethink Pharmacy Coverage
Organizations are still facing the significant financial challenges posed by GLP-1 receptor agonist medications. Recent survey data shows that…
-
-
FDA Accepts Generic Tirzepatide Applications for Diabetes and Weight Management
The Food and Drug Administration accepted two generic tirzepatide applications from a major pharmaceutical company. This candidate medication acts…
-
S-CELL Introduces Next-Generation GLP-1 Synbiotic
Driven by the growing popularity of prescription weight-loss and diabetes injections, consumer interest in boosting the appetite-regulating hormone GLP-1…
-
Physicians Prescribe GLP-1 Medications Off-Label to Young Children
Physicians are prescribing GLP-1 receptor agonists to children under twelve, despite the lack of specific federal approval. The Food…
-
GLP-1 Medications and Venous Health: Clinical Benefits and Vascular Risks
Glucagon-like peptide-1 receptor agonists, like semaglutide and tirzepatide, have changed how we treat obesity and type 2 diabetes. These…
-
Shame and Stigma Affect the GLP-1 Treatment Journey
Weight stigma has a measurable impact on clinical outcomes during pharmacological treatment for obesity. Glucagon-like peptide-1 receptor agonists, like…
-
GLP-1 Medications for Weight Loss and Lymphedema: Benefits, Risks & Latest Research
New weight loss medications are completely changing how doctors treat metabolic health. Brands like Ozempic, Wegovy, and Mounjaro help…
-
GLP-1 Therapy Linked to Sensory Disturbances in Type 2 Diabetes
Long-term use of glucagon-like peptide 1 receptor agonists is linked to a higher risk of disturbances in smell and…
-
GLP-1 Medications and Eating Disorders: Risks, Benefits, and What We Know
New weight loss drugs have completely changed how doctors treat obesity and type 2 diabetes. These famous medications, including…
-
Investigational DNA Platform Shows Extended Metabolic Benefits in Preclinical Diabetes Models
Researchers developed a new DNA-based delivery method that leads to sustained weight loss and improved glucose control in preclinical…
